Readiness of the Stroke Treatment in India: Still an Uphill Task!
- PMID: 37719342
- PMCID: PMC10504654
- DOI: 10.5005/jp-journals-10071-24525
Readiness of the Stroke Treatment in India: Still an Uphill Task!
Abstract
How to cite this article: Singhal V, Prabhakar H. Readiness of the Stroke Treatment in India: Still an Uphill Task! Indian J Crit Care Med 2023;27(9):607-608.
Keywords: Acute Ischemic stroke; Intravenous thrombolytic therapy; Low resources settings.
Copyright © 2023; The Author(s).
Conflict of interest statement
Source of support: Nil Conflict of interest: None
References
-
- Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA. 1995;274(13):1017–1025. - PubMed
-
- Clark WM, Wissman S, Albers GW, Jhamandas JH, Madden KP, Hamilton S. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: A randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. JAMA. 1999;282(21):2019–2026. doi: 10.1001/jama.282.21.2019. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources